RecruitingNCT06288282

Behavioral and Cognitive Predictors of Persistent Pain and Opioid Misuse in Chronic Pain


Sponsor

Icahn School of Medicine at Mount Sinai

Enrollment

130 participants

Start Date

Dec 20, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Chronic lower back pain (CLBP) affects approximately 20% of the global population. The study objective is to determine if impulsivity, inhibitory control, drug choice, and/or cognitive distortions predict opioid misuse and disability in patients with chronic pain. This is a prospective consented cross-sectional study characterizing behavioral and cognitive phenotypes using both patient-reported survey measures and cognitive testing. Outcome measures include correlations between impulsivity measures, opioid drug choice responses and cognitive distortion scores, and risk for opioid misuse (Primary outcomes: COMM scores, SOAPPR scores). Secondary outcomes is BPI measurement. A Certificate of Confidentiality will provide additional protections for participants.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • With diagnoses related to chronic lower back pain
  • Age above 18yrs
  • Non pregnant

Exclusion Criteria1

  • Cancer pain

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo Intervention

No intervention will be used.


Locations(1)

Mount Sinai Pain management centers

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06288282


Related Trials